| ¿µ¹® | toxicity | ÇÑ±Û | µ¶¼º |
|---|---|---|---|
| ¼³¸í | »ýü¿¡ ÀÖ¾î ¹Ù¶÷Á÷ÇÏÁö ¾ÊÀº ¾à¹° ÀÛ¿ëÀ» ¸»ÇÑ´Ù. ¾à¹°À» °ú·®À¸·Î »ç¿ëÇϸé Áßµ¶À» ÀÏÀ¸Å°¸ç, ½ÉÇÑ °æ¿ì¿¡´Â Á×À½¿¡ À̸£´Âµ¥ ÀÌ´Â ¾à¹°ÀÇ ±Þ¼º µ¶¼ºÀÌ´Ù. ¸¸¼º µ¶¼ºÀº ¼Ò·®À» Àå±â°£ ¹Ýº¹ ¼·ÃëÇÏ¿´À» ¶§ÀÇ µ¶¼ºÀÌ´Ù. °£, ÄáÆÏ µî ¿©·¯ Àå±â¿Í Á¶Á÷¿¡ ´ëÇÑ µ¶¼º ¿Ü¿¡, ±âÇüÀ¯¹ß¼º, ¹ß¾Ï¼º µîµµ ¾à¹°µ¶¼ºÀÌ´Ù. ¾à¹°µ¶¼ºÀÇ °¾àÀº ±Þ¼º µ¶¼º°Ë»ç(LD50), ¸¸¼º µ¶¼º°Ë»ç, ±âÇüÀ¯¹ß°Ë»ç, ¹ß¾Ï°Ë»ç, ¹ø½Ä°Ë»ç ±âŸ ¿©·¯ µ¿¹°°Ë»ç¿¡ ÀÇÇØ ÆÇÁ¤µÈ´Ù. |
||
| ¿µ¹® | alkaloid | ÇÑ±Û | ¾ËÄ®·ÎÀ̵å |
|---|---|---|---|
| ¼³¸í | ½Ä¹°Ã¼ ¼Ó¿¡ µé¾î ÀÖ´Â Áú¼Ò¸¦ Æ÷ÇÔÇÑ ¿°±â¼º À¯±â ÈÇÕ¹°À» ÅëÆ²¾î À̸£´Â ¸». µ¶¼ºÀÌ ÀÖÀ¸¸ç ÁøÅë, ÁøÇØ, ¸¶Ãë ÀÛ¿ëÀ» ÇÑ´Ù. ´ÏÄÚÆ¾, ¸ð¸£ÇÉ, Ä«ÆäÀÎ µûÀ§°¡ ÀÖ´Ù. Áú¼Ò°¡ Æ÷ÇԵǾî ÀÖ´Â ¿°±â¼ºÀ̸ç, ´ëºÎºÐÀº ºñ±³Àû ¼Ò·®À¸·Î »ç¶÷À̳ª µ¿¹°¿¡ ÇöÀúÇÑ ¾à¸®ÀÛ¿ëÀ» ³ªÅ¸³»´Â À¯±âÈÇÕ¹°ÀÌ´Ù. º¸ÅëÀº ½Ä¹°¿¡¼ À¯·¡µÈ ½Ä¹°¾ËÄ®·ÎÀ̵带 ¸»ÇÑ´Ù. ÇǸ®µò-Äû³î¸°-À̼ÒÄû³î¸°-ÇǷѸ®µò-ÇÇÆä¸®µò-Àε¹-Æ®·ÎÆÇ-Ç»¸° µî °í¸®±¸Á¶¸¦ °®´Â °ÍÀÌ ¸¹°í, ´ëºÎºÐÀº ¹«»ö°áÁ¤¼º °íü·Î ½Ä¹°ÀÇ ¾×Æ÷ ³»¿¡¼ »ê°ú¿°À» Çü¼ºÇϰí ÀÖ´Ù. ÇϳªÀÇ ½Ä¹°ÀÌ ¼öÁ¾ÀÇ ¾ËÄ®·ÎÀ̵带 Æ÷ÇÔÇÏ´Â °æ¿ì´Â º¸ÅëÀ̸ç, ¹Ì¼÷ÇÑ ¾ç±Íºñ ¾¾ÀÇ À¯¾×¿¡¼ ³ª¿Â ¾ÆÆí µî¿¡´Â ¾à 20Á¾·ù°¡ Æ÷ÇԵǾî ÀÖ´Ù. |
||
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
|---|---|
| PA | panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'... |
| EUROTOX | European Committee on Chronic Toxicity Hazards |
| I&T | intolerance and toxicity |
| TCLP | Toxicity Characteristic Leachate Procedure [EPA battery test] |
| CTC | Common Toxicity Criteria |
|---|---|
| DLT | Dose limiting toxicity |
| RRT | Regimen related toxicity |
| TCLP | Toxicity Characteristic Leaching Procedure |
| TIE | Toxicity Identification Evaluation |
rauwolfine (¶ó¿ùÇÉ
| vinca alkaloid | <drug, oncology> Anti-cancer drugs originally derived from the common periwinkle Catharantus roseus. Drugs of this type include vincristine, vinblastine. (14 Oct 1997) |
|---|---|
| vinca alkaloids | <chemical> A class of alkaloids from the genus of apocyanaceous woody herbs including periwinkles. They are some of the most useful antineoplastic agent. Pharmacological action: antineoplastic agent, phytogenic, vasodilator agents. (12 Dec 1998) |
| Vinca rosea | A species of myrtle (family Myrtaceae) used in various parts of the world as a home remedy; two active dimeric alkaloids obtained from this plant are vinblastine and vincristine. Synonym: periwinkle. (05 Mar 2000) |
| alkaloid | <chemistry, pharmacology> One of a large group of nitrogenous substances found in naturally in plants. They are usually very bitter and although the plant may be poisonous, many have extracts that are pharmacologically active. Examples are atropine, caffeine, coniine, morphine, nicotine, quinine, strychnine. The term is also applied to synthetic substances which have structures similar to plant alkaloids, such as procaine. (29 Sep 1997) |
| belladonna alkaloid | Atropine and related alkaloids which are anticholinergic. (27 Sep 1997) |
| ergot alkaloid-associated heart disease | Heart disease caused by endomyocardial fibrosis which extends into valve structures, producing stenosis and/or regurgitation, associated with ergot alkaloid use. (05 Mar 2000) |
| fixed alkaloid | A nonvolatile alkaloid. (05 Mar 2000) |
| acute toxicity | <pharmacology> Illness resulting from a single dose or exposure to a toxic substance. Compare: chronic toxicity. (06 May 1997) |
| chronic toxicity | <pharmacology> Illness caused by repeated or long-term exposure to low doses of a toxic substance. Compare: acute toxicity. (09 Oct 1997) |
| digitalis toxicity | A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor. Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels. (27 Sep 1997) |
| digoxin toxicity | A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor. Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels. (27 Sep 1997) |
| drug toxicity | The systemic effects of a drug that are related to the overall level of the medication in the bloodstream. Drug toxicity may occur with overdosage of a medication, accumulation of the drug in the body over time or the inability of the patients body to eliminate the drug. (27 Sep 1997) |
| oxygen toxicity | A body disturbance resulting from breathing high partial pressures of oxygen; characterised by visual and hearing abnormalities, unusual fatigue while breathing, muscular twitching, anxiety, confusion, incoordination, and convulsions; although the mechanism for development of the condition is obscure, a disruption of enzymatic activity is likely, perhaps as a result of free radical formation. Synonym: oxygen poisoning. (05 Mar 2000) |
| toxicity | The quality of being poisonous, especially the degree of virulence of a toxic microbe or of a poison. (18 Nov 1997) |
| toxicity test | <investigation> Controlled laboratory test to determine the toxicity of a chemical to an organism in terms of specific chemical concentrations. An acute toxicity test establishes the concentration required to kill a predetermined proportion of test organisms within a relatively short period of time, typically 4 days or less. A chronic toxicity test reveals the effects of a sublethal concentration applied throughout all or part of the life cycle. (12 Jan 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|